Servier offers a variety of tableting and encapsulation options to optimize your product’s therapeutic performance. Our tablet capabilities range from immediate, controlled and modified release to film and sugar coating, and we have the equipment and expertise to encapsulate powders, granules and micro-tablets.
We have high-performance production capabilities for a full range of dosage forms and product groups, including liquids, sprays and powders. Our manufacturing and packaging suites have separate air handling and filtration systems to ensure full quality control and assurance across the lifecycle of your product.
Servier provides custom manufacturing of APIs and HPAPIs from worldwide facilities. Our industry-leading methodologies, combined with state-of-the-art containment tools, enables us to handle your project from development through commercial phases, addressing any technical and regulatory challenges that may arise.
We manufacture pharmaceutical intermediates from state-of-the-art cGMP and FDA-approved chemical facilities around the world. Leveraging our integrated network of R&D, production and supply chain expertise, we provide intermediate manufacturing for both GMP and non-GMP requirements, from kilogram scale to several metric tons.
At Servier, we provide a number of cost-effective primary and secondary packaging options, including blisters, sachets and bottles. We strictly adhere to global standards for serialization and aggregation, and provide tamper-evident packaging and labeling in line with EU requirements.
Our pharmaceutical manufacturing plant in Madrid is certified in European registration dossiers for several current Servier Group products. The site’s state-of-the-art facilities and technology ensure high containment of your product during key stages of processing.
Our state-of-the-art facilities and technology in Madrid ensure high containment of your product during key stages of development.
International relationships are evolving rapidly. In this time of constant change and uncertainty, pharmaceutical outsourcing, while still offering many benefits, may also carry added risk — unless the outsourcing partner operates a highly integrated global network, has manufacturing locations in key growth markets and brings decades of experience to the table.
Paris, France, October 1, 2018 – Servier, an independent international pharmaceutical company, today announced the launch of InnoPreP™ – a new preparative chromatography service offered under its contract development and manufacturing business.